(Press-News.org)
NEW YORK, NY– The American Federation for Aging Research (AFAR) is pleased to announce a $450,000 grant from The Hearst Foundations in support of the Grants for Junior Faculty program.
The Grants for Junior Faculty provide early career investigators with up to $150,000 for one to two years to support research focused on aging processes and age-related diseases. The $450,000 grant from Hearst Foundations will fully underwrite three Grants for Junior Faculty over the next three years.
Selected through a rigorous review process, the 2024 recipient of the first Hearst Foundations Grant for Junior Faculty is Jonathan Nelson, PhD, Assistant Professor at Stony Brook University. His research project, titled “Understanding how ribosomal DNA maintenance sustains cellular longevity” seeks to identify the molecular mechanisms that achieve germline rDNA maintenance and understand how their activity and rDNA instability impacts organismal aging.
The impact of receiving a Grant for Junior Faculty from AFAR is far-reaching, providing flexible support at a criticaljuncture in an early investigator’s career when research funding is most difficult to obtain. Many AFAR grantees have leveraged this early support to obtain larger grants and awards.
"From the heads of labs at prominent research institutions, to biotech innovators developing therapeutics, so many leaders in aging research today first received a grant from AFAR early in their career," notes Stephanie Lederman, EdM, AFAR Executive Director. "The Hearst Foundations' support of the Grant for Junior Faculty program assures that even more talented investigators will be dedicated to the science that will help us all live healthier, longer."
The Hearst Foundations' support of the Grants for Junior Faculty program builds on a decades-long collaboration between the organizations. For over twenty-two years, the Hearst Foundations have bolstered AFAR's research grants program with $1,350,000 in support.
“The Hearst Foundations are proud to continue to partner with the American Federation for Aging Research (AFAR) to support and help recruit early career investigators in this growing field. A robust pipeline of researchers dedicated to aging is vital to support a growing older population. We look forward to aiding AFAR as they expand their impact nationwide and advance healthy aging through biomedical research,” says Donna Kalajian Lagani, Eastern Director, the Hearst Foundations.
The Grant for Junior Faculty is considered the anchor of AFAR's grants portfolio, which assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research. For more than four decades, AFAR has served as the field’s talent incubator, providing close to $200 million to some 4,400 investigators at premier research institutions to date—and growing.
Learn more about the Grants for Junior Faculty program here.
###
About The Hearst Foundations
The Hearst Foundations are a national philanthropic resource for nonprofit organizations and institutions working in the fields of education, health, culture and social service. Their work helps to ensure that people of all backgrounds have the opportunity to build healthy, productive and satisfying lives. Since their creation in the 1940s, the Hearst Foundations have awarded more than $1.5 billion in funding across over 22,730 grants, reflecting the philanthropic interests of William Randolph Hearst. In 2023, the Hearst Foundations made 283 grants totaling $68.075 million. For more information about the Hearst Foundations, please visit www.HearstFDN.org.
About AFAR
The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the field’s talent incubator, providing close to $200 million to some 4,400 investigators at premier research institutions to date—and growing. In 2023, AFAR provided approximately $12,500,000 to more than 60 investigators. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and interdisciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delay—or even prevent—many chronic diseases, often at the same time. They are discovering that it is never too late—or too early—to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of life—at any age. Learn more at www.afar.org.
END
Using two optically trapped glass nanoparticles, researchers observed a novel collective Non-Hermitian and nonlinear dynamic driven by nonreciprocal interactions. This contribution expands traditional optical levitation with tweezer arrays by incorporating the so called non-conservative interactions. Their findings, supported by an analytical model developed by collaborators from Ulm University and the University of Duisburg-Essen, were recently published in Nature Physics.
Fundamental forces like gravity and electromagnetism are reciprocal, meaning two ...
New, non-native plant species are constantly being discovered in Svalbard, and researchers are working to ascertain what threat these species pose to the native plants.
So far, the Arctic has managed to avoid one of the most serious threats to biodiversity on Earth. This is also true for Svalbard, but things could change very quickly, and researchers want to find out how to counteract this threat.
“Increased human activity heightens the risk of new plant species being introduced. And climate change increases the risk of invasive species establishing themselves,” says Kristine Bakke Westergaard.
She is an associate ...
Available to anyone, anywhere, at anytime, Texl.org allows individuals and organizations to create scientifically valid surveys in less than five minutes. In drag-and-drop fashion, survey creators can choose from an ever-growing list of 50 validated scales, measuring aspects ranging from team conflict to personal initiative and transformational leadership.
“The point of science is to develop knowledge that ultimately is to the benefit of society. Unfortunately, we are not always great in translating our knowledge so that it is usable for practitioners out there. With Texl we’re changing that,” explains Professor Niels Van Quaquebeke, ...
While chemotherapy has advanced in personalization, personalized radiation therapy for cancer remains underdeveloped. Current cancer treatment methods – including radiation therapy – are intricate, lack personalization, and rely heavily on the expertise of medical teams. Medical image analysis and machine learning hold great promise for enhancing personalized oncology. However, challenges persist such as limited high-quality data and data complexity.
Wazir Muhammad, Ph.D., principal investigator and ...
HOUSTON and MIAMI ― The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement for the purpose of accelerating the development of ivonescimab.
Leveraging MD Anderson’s clinical infrastructure and research expertise together with Summit’s innovative, investigational, potential first-in-class PD-1/VEGF bispecific antibody, the collaboration is designed to quickly discover additional opportunities for ivonescimab, including several tumors outside of its current development plan. MD Anderson will lead multiple clinical trials in several tumor types to evaluate the safety and potential clinical ...
Scientists have known from ice core research that it's easier to melt an ice sheet than to freeze it up again. Now, they know at least part of the reason why, and it has to do with ice's "sponginess," according to a new study published July 24 in The Cryosphere.
The study uses a physics-based numerical model to assess the impacts of warming and cooling on firn, the porous layer between snow and glacial ice, over the entire Greenland Ice Sheet. Megan Thompson-Munson, a CIRES and ATOC PhD student, led the study alongside ...
Houston, Texas, July 25, 2024 – The Texas Heart Institute (THI) and BiVACOR®, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024. BiVACOR’s TAH is a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart.
The first-in-human clinical ...
University of Washington Researchers Take Flight with New Insights on Bat Evolution
Video Interview with Authors - https://youtu.be/6rogrh2_HN0
In new research published in PeerJ Life & Environment, researchers from the University of Washington, University of Texas at Austin and Oregon Institute of Technology, led by undergraduate student Abby Burtner, have advanced our understanding of the evolutionary origins of flight in bats. The study, titled "Gliding toward an Understanding of the Origin of Flight in Bats," employs phylogenetic comparative methods to explore the evolutionary transition from gliding to powered flight in these unique mammals.
Bats ...
HOUSTON – (June 25, 2024) – Rice University President Reginald DesRoches joined Rice360 Institute for Global Health Technologies Co-Director Maria Oden and Rice360 supporters on a trip to Africa this summer marking significant milestones on the road to ending preventable newborn deaths in the sub-Saharan region. Rice360 is one of 22 organizations in the Newborn Essential Solutions and Technologies (NEST360) international alliance, and this trip signified Rice’s continued collaboration ...
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.
The funding round was backed by Oshen Holdings, DSW Ventures, SFC Capital, Boundary Capital and private investors including several leading scientists and surgeons. It will enable the company to complete pre-clinical testing of its first product range and seek FDA clearance for entry into the US market.
4D is a UK-based company whose innovative biomaterial has potential to be used for a wide range of 3D printed implants and surgical devices. Its product 4Degra is a resorbable biomaterial that is being used to develop ...
